14 % decline in “Moderna” shares

On December 10, “Moderna”, a biotechnology company, witnessed a 14 % decrease. The lowest share price of the day set to become $ 233.51, in contrast, at the end of trading on December 9 it was recorded $ 272.21.

Later, the company then recovered some of its shares, and by 9:40 p.m. in terms of Moscow time, they abated about 5% indicating $ 258.6.

Investors were displeased with the company's report on the first phase of influenza vaccination based on the mRNA technology utilized in the coronavirus vaccine.

“Moderna” announced the results of the survey on December 10. Pursuant to the findings, influenza vaccination has led to the emergence of immunity against 29 variants of influenza virus in young and elderly people.